{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T11:13:13Z","timestamp":1718104393050},"reference-count":69,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81170647","91029742","30973207"],"award-info":[{"award-number":["81170647","91029742","30973207"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1016\/j.ejphar.2012.12.025","type":"journal-article","created":{"date-parts":[[2013,1,10]],"date-time":"2013-01-10T22:32:23Z","timestamp":1357857143000},"page":"33-39","source":"Crossref","is-referenced-by-count":9,"title":["Mechanisms of epoxyeicosatrienoic acids to improve cardiac remodeling in chronic renal failure disease"],"prefix":"10.1016","volume":"701","author":[{"given":"Kun","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ju","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huanji","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiyi","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingfeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2012.12.025_bib1","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.hfc.2011.08.010","article-title":"Role of apoptosis in adverse ventricular remodeling","volume":"8","author":"Abbate","year":"2012","journal-title":"Heart Fail Clin."},{"key":"10.1016\/j.ejphar.2012.12.025_bib2","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1073\/pnas.0811022106","article-title":"Soluble epoxide hydrolase plays an essential role in angiotensin II-induced cardiac hypertrophy","volume":"106","author":"Ai","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejphar.2012.12.025_bib4","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.yjmcc.2009.01.009","article-title":"Protective actions of epoxyeicosatrienoic acid: dual targeting of cardiovascular PI3K and KATP channels","volume":"46","author":"Bodiga","year":"2009","journal-title":"J. Mol. Cell Cardiol."},{"key":"10.1016\/j.ejphar.2012.12.025_bib5","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1172\/JCI13210","article-title":"Arachidonic acid as a bioactive molecule","volume":"107","author":"Brash","year":"2001","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejphar.2012.12.025_bib6","doi-asserted-by":"crossref","first-page":"e26591","DOI":"10.1371\/journal.pone.0026591","article-title":"Endogenous epoxygenases are modulators of monocyte\/macrophage activity","volume":"6","author":"Bystrom","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2012.12.025_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5301\/JN.2010.2030","article-title":"Epidemiology and pathophysiology of left ventricular abnormalities in chronic kidney disease: a review","volume":"24","author":"Cerasola","year":"2011","journal-title":"J. Nephrol."},{"key":"10.1016\/j.ejphar.2012.12.025_bib8","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1177\/0091270010397049","article-title":"Pharmacokinetics and pharmacodynamics of AR9281, an inhibitor of soluble epoxide hydrolase, in single- and multiple-dose studies in healthy human subjects","volume":"52","author":"Chen","year":"2012","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.ejphar.2012.12.025_bib9","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1161\/01.CIR.99.23.3071","article-title":"Increased cardiomyocyte apoptosis and changes in proapoptotic and antiapoptotic genes bax and bcl-2 during left ventricular adaptations to chronic pressure overload in the rat","volume":"99","author":"Condorelli","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2012.12.025_bib10","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1096\/fj.10-171488","article-title":"Endothelial CYP epoxygenase overexpression and soluble epoxide hydrolase disruption attenuate acute vascular inflammatory responses in mice","volume":"25","author":"Deng","year":"2011","journal-title":"FASEB J."},{"key":"10.1016\/j.ejphar.2012.12.025_bib11","doi-asserted-by":"crossref","first-page":"H724","DOI":"10.1152\/ajpheart.00979.2007","article-title":"Multiple antiapoptotic targets of the PI3K\/Akt survival pathway are activated by epoxyeicosatrienoic acids to protect cardiomyocytes from hypoxia\/anoxia","volume":"294","author":"Dhanasekaran","year":"2008","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.ejphar.2012.12.025_bib12","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1161\/CIRCRESAHA.109.216101","article-title":"Smad3 signaling critically regulates fibroblast phenotype and function in healing myocardial infarction","volume":"107","author":"Dobaczewski","year":"2010","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2012.12.025_bib13","doi-asserted-by":"crossref","first-page":"R321","DOI":"10.1152\/ajpregu.00606.2011","article-title":"Reno-protective mechanisms of epoxyeicosatrienoic acids in cardiovascular disease","volume":"302","author":"Elmarakby","year":"2012","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.ejphar.2012.12.025_bib14","doi-asserted-by":"crossref","first-page":"R1307","DOI":"10.1152\/ajpregu.00759.2010","article-title":"Deletion of soluble epoxide hydrolase gene improves renal endothelial function and reduces renal inflammation and injury in streptozotocin-induced type 1 diabetes","volume":"301","author":"Elmarakby","year":"2011","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.ejphar.2012.12.025_bib15","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1093\/ndt\/gfm542","article-title":"Cardiovascular remodelling and extracellular fluid excess in early stages of chronic kidney disease","volume":"23","author":"Essig","year":"2008","journal-title":"Nephrol. Dial. Transplant"},{"key":"10.1016\/j.ejphar.2012.12.025_bib16","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/S0022-2275(20)41131-9","article-title":"Epoxyeicosatrienoic acid metabolism in arterial smooth muscle cells","volume":"36","author":"Fang","year":"1995","journal-title":"J. Lipid. Res."},{"key":"10.1016\/j.ejphar.2012.12.025_bib17","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1161\/01.CIR.0000164237.58200.5A","article-title":"Requirement of nuclear factor-kappaB in angiotensin II- and isoproterenol-induced cardiac hypertrophy in vivo","volume":"111","author":"Freund","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2012.12.025_bib18","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1146\/annurev.physiol.65.092101.142243","article-title":"Cardiac hypertrophy: the good, the bad, and the ugly","volume":"65","author":"Frey","year":"2003","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.ejphar.2012.12.025_bib19","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1093\/ndt\/gfp007","article-title":"Oral charcoal adsorbent (AST-120) prevents progression of cardiac damage in chronic kidney disease through suppression of oxidative stress","volume":"24","author":"Fujii","year":"2009","journal-title":"Nephrol. Dial. Transplant"},{"key":"10.1016\/j.ejphar.2012.12.025_bib20","doi-asserted-by":"crossref","first-page":"H2838","DOI":"10.1152\/ajpheart.00186.2008","article-title":"Effects of the selective EET antagonist, 14,15-EEZE, on cardioprotection produced by exogenous or endogenous EETs in the canine heart","volume":"294","author":"Gross","year":"2008","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.ejphar.2012.12.025_bib21","doi-asserted-by":"crossref","first-page":"H853","DOI":"10.1152\/ajpheart.00154.2012","article-title":"Pharmacological inhibition of soluble epoxide hydrolase provides cardioprotection in hyperglycemic rats","volume":"303","author":"Guglielmino","year":"2012","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.ejphar.2012.12.025_bib22","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/S0735-1097(98)00407-0","article-title":"Increased left ventricular mass and hypertrophy are associated with increased risk for sudden death","volume":"32","author":"Haider","year":"1998","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ejphar.2012.12.025_bib23","first-page":"E269","article-title":"Inhibition of renin release by 14,15-epoxyeicosatrienoic acid in renal cortical slices","volume":"258","author":"Henrich","year":"1990","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.ejphar.2012.12.025_bib24","doi-asserted-by":"crossref","first-page":"F342","DOI":"10.1152\/ajprenal.00004.2007","article-title":"Increasing or stabilizing renal epoxyeicosatrienoic acid production attenuates abnormal renal function and hypertension in obese rats","volume":"293","author":"Huang","year":"2007","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.ejphar.2012.12.025_bib25","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1152\/physrev.00021.2011","article-title":"Epoxides and soluble epoxide hydrolase in cardiovascular physiology","volume":"92","author":"Imig","year":"2012","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.ejphar.2012.12.025_bib26","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1038\/nrd2875","article-title":"Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases","volume":"8","author":"Imig","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejphar.2012.12.025_bib27","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1161\/01.HYP.0000176237.74820.75","article-title":"An orally active epoxide hydrolase inhibitor lowers blood pressure and provides renal protection in salt-sensitive hypertension","volume":"46","author":"Imig","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2012.12.025_bib28","doi-asserted-by":"crossref","first-page":"e11979","DOI":"10.1371\/journal.pone.0011979","article-title":"Inhibition of the soluble epoxide hydrolase promotes albuminuria in mice with progressive renal disease","volume":"5","author":"Jung","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2012.12.025_bib29","doi-asserted-by":"crossref","first-page":"6867","DOI":"10.1038\/sj.onc.1203219","article-title":"How NF-kappaB is activated: the role of the IkappaB kinase (IKK) complex","volume":"18","author":"Karin","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/j.ejphar.2012.12.025_bib30","article-title":"Soluble epoxide hydrolase inhibition exerts beneficial anti-remodeling actions post-myocardial infarction","author":"Kompa","year":"2012","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ejphar.2012.12.025_bib31","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1161\/HYPERTENSIONAHA.107.092403","article-title":"Effects of fenofibrate on cardiac remodeling in aldosterone-induced hypertension","volume":"50","author":"Lebrasseur","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2012.12.025_bib32","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1056\/NEJM199005313222203","article-title":"Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study","volume":"322","author":"Levy","year":"1990","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2012.12.025_bib33","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.yjmcc.2009.08.017","article-title":"Beneficial effects of soluble epoxide hydrolase inhibitors in myocardial infarction model: Insight gained using metabolomic approaches","volume":"47","author":"Li","year":"2009","journal-title":"J. Mol. Cell Cardiol."},{"key":"10.1016\/j.ejphar.2012.12.025_bib34","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1124\/jpet.111.180505","article-title":"Epoxyeicosatrienoic acids attenuate reactive oxygen species level, mitochondrial dysfunction, caspase activation, and apoptosis in carcinoma cells treated with arsenic trioxide","volume":"339","author":"Liu","year":"2011","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2012.12.025_bib35","doi-asserted-by":"crossref","first-page":"16747","DOI":"10.1073\/pnas.0508081102","article-title":"The antiinflammatory effect of laminar flow: the role of PPARgamma, epoxyeicosatrienoic acids, and soluble epoxide hydrolase","volume":"102","author":"Liu","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejphar.2012.12.025_bib36","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1385\/CBB:47:1:87","article-title":"Prevention of hypertension in DOCA-salt rats by an inhibitor of soluble epoxide hydrolase","volume":"47","author":"Loch","year":"2007","journal-title":"Cell Biochem. Biophys."},{"key":"10.1016\/j.ejphar.2012.12.025_bib37","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1124\/jpet.110.167544","article-title":"Inhibition or deletion of soluble epoxide hydrolase prevents hyperglycemia, promotes insulin secretion, and reduces islet apoptosis","volume":"334","author":"Luo","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2012.12.025_bib38","doi-asserted-by":"crossref","first-page":"9038","DOI":"10.1073\/pnas.1103482108","article-title":"Soluble epoxide hydrolase deficiency alters pancreatic islet size and improves glucose homeostasis in a model of insulin resistance","volume":"108","author":"Luria","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejphar.2012.12.025_bib39","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1111\/j.1476-5381.2010.00750.x","article-title":"Renin-angiotensin-aldosterone system blockade for cardiovascular diseases: current status","volume":"160","author":"Ma","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2012.12.025_bib40","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.yjmcc.2011.11.015","article-title":"Soluble epoxide hydrolase inhibition improves myocardial perfusion and function in experimental heart failure","volume":"52","author":"Merabet","year":"2012","journal-title":"J. Mol. Cell Cardiol."},{"key":"10.1016\/j.ejphar.2012.12.025_bib41","doi-asserted-by":"crossref","first-page":"H679","DOI":"10.1152\/ajpheart.00533.2009","article-title":"Inhibition of soluble epoxide hydrolase preserves cardiomyocytes: role of STAT3 signaling","volume":"298","author":"Merkel","year":"2010","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.ejphar.2012.12.025_bib42","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2220\/biomedres.32.83","article-title":"Left ventricular hypertrophy is associated with inflammation in sodium loaded subtotal nephrectomized rats","volume":"32","author":"Moriguchi","year":"2011","journal-title":"Biomed. Res."},{"key":"10.1016\/j.ejphar.2012.12.025_bib43","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1002\/jcp.21356","article-title":"Cytochrome P450 (CYP) 2J2 gene transfection attenuates MMP-9 via inhibition of NF-kappabeta in hyperhomocysteinemia","volume":"215","author":"Moshal","year":"2008","journal-title":"J. Cell Physiol."},{"key":"10.1016\/j.ejphar.2012.12.025_bib44","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1016\/j.jchromb.2008.11.032","article-title":"Recent progress in the analysis of uremic toxins by mass spectrometry","volume":"877","author":"Niwa","year":"2009","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.ejphar.2012.12.025_bib45","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1126\/science.285.5431.1276","article-title":"Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids","volume":"285","author":"Node","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2012.12.025_bib46","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1042\/CS20080039","article-title":"Administration of a substituted adamantyl urea inhibitor of soluble epoxide hydrolase protects the kidney from damage in hypertensive Goto-Kakizaki rats","volume":"116","author":"Olearczyk","year":"2009","journal-title":"Clin. Sci."},{"key":"10.1016\/j.ejphar.2012.12.025_bib47","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.yjmcc.2004.05.015","article-title":"The role of phosphoinositide-3 kinase and PTEN in cardiovascular physiology and disease","volume":"37","author":"Oudit","year":"2004","journal-title":"J. Mol. Cell Cardiol."},{"key":"10.1016\/j.ejphar.2012.12.025_bib48","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1161\/01.HYP.0000210549.47167.db","article-title":"Heart failure and left ventricular remodeling after reperfused acute myocardial infarction in patients with hypertension","volume":"47","author":"Parodi","year":"2006","journal-title":"Hypertension"},{"issue":"Suppl. 11","key":"10.1016\/j.ejphar.2012.12.025_bib49","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1093\/ndt\/17.suppl_11.28","article-title":"The malnutrition, inflammation, and atherosclerosis (MIA) syndrome\u2014The heart of the matter","volume":"17","author":"Pecoits-Filho","year":"2002","journal-title":"Nephrol. Dial. Transplant"},{"key":"10.1016\/j.ejphar.2012.12.025_bib50","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s00467-004-1713-8","article-title":"Growth hormone resistance in uremia, a role for impaired JAK\/STAT signaling","volume":"20","author":"Rabkin","year":"2005","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.ejphar.2012.12.025_bib51","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1152\/physrev.00021.2001","article-title":"P-450 metabolites of arachidonic acid in the control of cardiovascular function","volume":"82","author":"Roman","year":"2002","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.ejphar.2012.12.025_bib52","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1681\/ASN.2006050462","article-title":"Myocardial ultrasound tissue characterization in patients with chronic renal failure","volume":"18","author":"Salvetti","year":"2007","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.ejphar.2012.12.025_bib53","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1161\/01.RES.0000139436.89654.c8","article-title":"Enhanced postischemic functional recovery in CYP2J2 transgenic hearts involves mitochondrial ATP-sensitive K+ channels and p42\/p44 MAPK pathway","volume":"95","author":"Seubert","year":"2004","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2012.12.025_bib54","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1161\/01.RES.0000237390.92932.37","article-title":"Role of soluble epoxide hydrolase in postischemic recovery of heart contractile function","volume":"99","author":"Seubert","year":"2006","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2012.12.025_bib55","doi-asserted-by":"crossref","first-page":"40504","DOI":"10.1074\/jbc.M008106200","article-title":"Targeted disruption of soluble epoxide hydrolase reveals a role in blood pressure regulation","volume":"275","author":"Sinal","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2012.12.025_bib56","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1081\/JDI-100001291","article-title":"Parathormon, calcium, phosphorus, and left ventricular structure and function in normotensive hemodialysis patients","volume":"23","author":"Strozecki","year":"2001","journal-title":"Ren. Fail"},{"key":"10.1016\/j.ejphar.2012.12.025_bib57","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1161\/CIRCULATIONAHA.106.643585","article-title":"Tumor necrosis factor-alpha mediates cardiac remodeling and ventricular dysfunction after pressure overload state","volume":"115","author":"Sun","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2012.12.025_bib58","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s10741-010-9197-z","article-title":"Hypertension, left ventricular hypertrophy and chronic kidney disease","volume":"16","author":"Taddei","year":"2011","journal-title":"Heart Fail Rev."},{"key":"10.1016\/j.ejphar.2012.12.025_bib59","first-page":"999","article-title":"The relationship between insulin resistance and left ventricular hypertrophy in patients with early chronic kidney disease","volume":"48","author":"Wang","year":"2009","journal-title":"Zhonghua Nei Ke Za Zhi"},{"key":"10.1016\/j.ejphar.2012.12.025_bib60","doi-asserted-by":"crossref","first-page":"12551","DOI":"10.1074\/jbc.272.19.12551","article-title":"Molecular cloning, expression, and functional significance of a cytochrome P450 highly expressed in rat heart myocytes","volume":"272","author":"Wu","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2012.12.025_bib61","doi-asserted-by":"crossref","first-page":"18733","DOI":"10.1073\/pnas.0609158103","article-title":"Prevention and reversal of cardiac hypertrophy by soluble epoxide hydrolase inhibitors","volume":"103","author":"Xu","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejphar.2012.12.025_bib62","doi-asserted-by":"crossref","first-page":"997","DOI":"10.2337\/db09-1241","article-title":"Increased CYP2J3 expression reduces insulin resistance in fructose-treated rats and db\/db mice","volume":"59","author":"Xu","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.ejphar.2012.12.025_bib63","doi-asserted-by":"crossref","first-page":"H142","DOI":"10.1152\/ajpheart.00783.2006","article-title":"Cytochrome P-450 epoxygenases protect endothelial cells from apoptosis induced by tumor necrosis factor-alpha via MAPK and PI3K\/Akt signaling pathways","volume":"293","author":"Yang","year":"2007","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.ejphar.2012.12.025_bib64","doi-asserted-by":"crossref","first-page":"36059","DOI":"10.1074\/jbc.R100030200","article-title":"Epoxygenase pathways of arachidonic acid metabolism","volume":"276","author":"Zeldin","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2012.12.025_bib65","doi-asserted-by":"crossref","first-page":"6402","DOI":"10.1016\/S0021-9258(18)53266-X","article-title":"Regio- and enantiofacial selectivity of epoxyeicosatrienoic acid hydration by cytosolic epoxide hydrolase","volume":"268","author":"Zeldin","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2012.12.025_bib66","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1161\/CIRCRESAHA.111.259325","article-title":"Homocysteine upregulates soluble epoxide hydrolase in vascular endothelium in vitro and in vivo","volume":"110","author":"Zhang","year":"2012","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2012.12.025_bib68","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1089\/hum.2011.135","article-title":"Delivery of AAV2-CYP2J2 protects remnant kidney in the 5\/6 nephrectomized rat via inhibition of apoptosis and fibrosis","volume":"23","author":"Zhao","year":"2012","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ejphar.2012.12.025_bib69","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1194\/jlr.M017319","article-title":"Epoxyeicosatrienoic acids protect rat hearts against tumor necrosis factor-alpha-induced injury","volume":"53","author":"Zhao","year":"2012","journal-title":"J. Lipid. Res."},{"key":"10.1016\/j.ejphar.2012.12.025_bib70","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1111\/j.1523-1755.2004.00530.x","article-title":"Left ventricular mass monitoring in the follow-up of dialysis patients: prognostic value of left ventricular hypertrophy progression","volume":"65","author":"Zoccali","year":"2004","journal-title":"Kidney Int."},{"key":"10.1016\/j.ejphar.2012.12.025_bib71","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1755-6686.2011.00201.x","article-title":"Malnutrition-inflammation-atherosclerosis syndrome in patients with end-stage renal disease","volume":"37","author":"Zyga","year":"2011","journal-title":"J. Ren. Care"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299912010424?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299912010424?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,2,5]],"date-time":"2022-02-05T18:52:08Z","timestamp":1644087128000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299912010424"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":69,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["S0014299912010424"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2012.12.025","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2]]}}}